Our COVID-19 news

The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested $5 million into a new Monash laboratory dedicated to developing mRNA vaccines and therapeutics for future clinical trials.

A collaborative team of Melbourne researchers from Monash University and the University of Melbourne have received $5.4 million from the Victorian government to establish The Victorian mRNA Innovation Hub to develop next-generation mRNA vaccines and

Influenza, commonly referred to as “flu”, is a major global public health concern and a huge economic burden to societies.

Leading the Knott Lab at Monash’s Biomedicine Discovery Institute, Dr Knott is one of only three researchers in Australia to receive the $8 million, eight-year fellowship to develop Australia’s next generation of biomedical research

As indicated in our August statement on the Monash BDI news page, Dr Kylie Wagstaff has been working to establish a blinded and randomised clinical trial of Ivermectin.

Despite strong competition, Victoria has encouraged Moderna to come to its state. With the location of it’s manufacturing site looking to be confirmed by the end of April, our RNA experts provide insights into just how important choosing the

A Monash University study has demonstrated that full PPE, involving a fit-tested N95 mask, in conjunction with a HEPA filtration system, offers health workers in a hospital setting the best protection against virus aerosol exposure.

Professor John Carroll, the Director of the Monash Biomedicine Discovery Institute and a member of the mRNA Victoria Advisory Group, has stressed the importance of establishing vaccine research and manufacturing options in Australia in a Sydney

The immune system is vitally important for resolving COVID-19 when individuals are infected with the SARS-CoV-2 virus. Moreover, the vaccines that are being administered to millions of people across the globe are designed to ‘pre-warn and